S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Ascendis Pharma A/S

ASND Healthcare
$231.02 +$5.05 (2.23%)
Market Cap: $14.18 B
Gurus Holding
1
Popularity Rank
#4872
% of Shares Held
0.20%
Net Activity (Q4 2025)
+$7.46 M

Guru Ownership Trend

Guru Analysis for Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S (ASND), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $28.88 M.

Top institutional holders include Louis Moore Bacon.

Institutional sentiment is currently Bullish. This is evidenced by a $7.46 M net inflow during the quarter.

Recent activity highlights Louis Moore Bacon who increased their stake by 38.9%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$7.46 M
Total Buy Value
New Buys 0
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Ascendis Pharma A/S (ASND)

Major holders include Louis Moore Bacon ($26.66 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 125,000 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.46 M, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in ASND during the most recent reporting period.

Yes, 0 managers opened new positions in ASND, and 1 increased their existing holdings. The total reported buy value was $7.46 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.38% Add 38.9% 125,000 $26.66 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form